Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | POPDC3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | COPS7A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SCD5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC084219.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CLSTN2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RBMY1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CTD-2528L19.4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | GOT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |